MY103912A - Adriamycin - Google Patents

Adriamycin

Info

Publication number
MY103912A
MY103912A MYPI88001026A MYPI19881026A MY103912A MY 103912 A MY103912 A MY 103912A MY PI88001026 A MYPI88001026 A MY PI88001026A MY PI19881026 A MYPI19881026 A MY PI19881026A MY 103912 A MY103912 A MY 103912A
Authority
MY
Malaysia
Prior art keywords
alpha
beta
adriamycin
reactive
novel
Prior art date
Application number
MYPI88001026A
Other languages
English (en)
Inventor
Di Marco Aurelio
Arcamone Federico
Penco Sergio
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of MY103912A publication Critical patent/MY103912A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MYPI88001026A 1974-03-22 1988-09-14 Adriamycin MY103912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1278374A GB1457632A (en) 1974-03-22 1974-03-22 Adriamycins

Publications (1)

Publication Number Publication Date
MY103912A true MY103912A (en) 1993-10-30

Family

ID=10011048

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI88001026A MY103912A (en) 1974-03-22 1988-09-14 Adriamycin

Country Status (18)

Country Link
US (1) US4058519A (enExample)
JP (1) JPS5840555B2 (enExample)
AT (1) AT338420B (enExample)
AU (1) AU497500B2 (enExample)
BE (1) BE826978A (enExample)
CA (1) CA1046507A (enExample)
CH (1) CH612947A5 (enExample)
DE (1) DE2510866C3 (enExample)
DK (1) DK153158C (enExample)
ES (1) ES435833A1 (enExample)
FR (1) FR2264555B1 (enExample)
GB (1) GB1457632A (enExample)
HK (1) HK882A (enExample)
MY (1) MY103912A (enExample)
NL (1) NL176635C (enExample)
SE (1) SE434844B (enExample)
SU (1) SU583763A3 (enExample)
ZA (1) ZA751781B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133877A (en) * 1976-07-08 1979-01-09 Societa Farmaceutici Italia S.P.A. Anthracycline ethers and use therefor
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
US4345068A (en) * 1979-11-22 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
JPS57106695A (en) * 1980-11-01 1982-07-02 Erba Carlo Spa Anthracycline g lycoside compound
ATE15375T1 (de) * 1980-11-01 1985-09-15 Erba Farmitalia Anthracyclin-glycoside, zwischenprodukte, verfahren zu beider herstellung und arzneimittel.
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
DE3500029A1 (de) * 1985-01-02 1986-09-04 Farmitalia Carlo Erba S.p.A., Mailand/Milano Anthracyclinester
GB2169284A (en) * 1985-01-05 1986-07-09 Erba Farmitalia 4'-Epidoxorubicin-14-esters
JPS61172891A (ja) * 1985-01-24 1986-08-04 フア−ミタリア・カルロ・エルバ・ソシエタ・ペル・アツイオ−ニ アントラサイクリン類エステルの製法
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
ES2151632T3 (es) 1996-12-16 2001-01-01 Pharmachemie Bv Un proceso para preparar epirubicina o sales de adicion de acidos de la misma a partir de daunorubicina.
ES2235518T3 (es) * 1998-10-16 2005-07-01 Mercian Corporation Cristalizacion de hidrocloruro de doxorubicina.
KR100785966B1 (ko) * 2000-08-10 2007-12-14 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
KR100850408B1 (ko) * 2000-08-10 2008-08-04 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
ATE520702T1 (de) * 2003-07-02 2011-09-15 Solux Corp Thermisch stabiles kristallines epirubicin- hydrochlorid und herstellungsverfahren dafür
EP1845974A1 (en) 2005-01-21 2007-10-24 Astex Therapeutics Limited Pharmaceutical compounds
PL375008A1 (pl) 2005-05-12 2006-11-13 Institut National De La Sante Et De La Recherche Medicale, Inserm Nowe zastosowanie medyczne chlorowodorku epirubicyny
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
KR20110098849A (ko) 2008-12-23 2011-09-01 파마셋 인코포레이티드 뉴클레오시드 유사체
KR20110099138A (ko) 2008-12-23 2011-09-06 파마셋 인코포레이티드 뉴클레오시드 포스포르아미데이트
SG172363A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Synthesis of purine nucleosides
PL2552930T3 (pl) 2010-03-31 2016-02-29 Gilead Pharmasset Llc Krystaliczny 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1-(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian (S)-izopropylu
CN108473523B (zh) * 2016-01-11 2022-03-15 浙江海正药业股份有限公司 一种盐酸表柔比星的制备方法及其中间体
MX381890B (es) 2016-03-15 2025-03-13 Oryzon Genomics Sa Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356674A (en) * 1961-07-07 1967-12-05 Rikagaku Kenkyusho 3-c-hydroxymethyl-3, 5-didesoxy-l-lyxofuranose and its derivatives, and a process for the production thereof
US3427300A (en) * 1965-11-12 1969-02-11 Merck & Co Inc Anti-inflammatory steroid 2'-acetamido-2'-deoxy-glucoside compounds
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
US3629231A (en) * 1968-05-23 1971-12-21 Biorex Laboratories Ltd Derivatives of glycyrrhetinic acid
US3651090A (en) * 1969-12-17 1972-03-21 Cutter Lab 1 3-dioxolan-4-yl-alkyl guanidines
FR2183710A1 (en) * 1972-05-06 1973-12-21 Farmaceutici Italia Daunomycin (hydrochloride) prepn - by reaction of daunomycinone with daunosamines, useful as antitumour agent and anti-leucemic

Also Published As

Publication number Publication date
AT338420B (de) 1977-08-25
GB1457632A (en) 1976-12-08
DK153158C (da) 1989-01-16
ZA751781B (en) 1976-02-25
NL7502934A (nl) 1975-09-24
SE7503215L (enExample) 1975-09-23
CH612947A5 (enExample) 1979-08-31
NL176635B (nl) 1984-12-17
SU583763A3 (ru) 1977-12-05
AU7926375A (en) 1976-09-23
DK114475A (enExample) 1975-09-23
BE826978A (fr) 1975-09-22
FR2264555B1 (enExample) 1980-01-11
US4058519A (en) 1977-11-15
DE2510866A1 (de) 1975-10-02
DK153158B (da) 1988-06-20
NL176635C (nl) 1985-05-17
ATA207475A (de) 1976-12-15
FR2264555A1 (enExample) 1975-10-17
CA1046507A (en) 1979-01-16
SE434844B (sv) 1984-08-20
JPS5840555B2 (ja) 1983-09-06
HK882A (en) 1982-01-22
ES435833A1 (es) 1976-12-01
DE2510866C3 (de) 1980-08-14
DE2510866B2 (de) 1979-12-06
JPS50126656A (enExample) 1975-10-04
AU497500B2 (en) 1978-12-14

Similar Documents

Publication Publication Date Title
MY103912A (en) Adriamycin
SE7610564L (sv) Forfarande for framstellning av glykosidforeningar
CA1022701A (en) Anti-fog surgical face mask with slits
AU500439B2 (en) Anthracycline glycosides
IE782421L (en) Pleuromutilin glycosides
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
IL51264A (en) Metal derivatives of anthracycline glycoside antibiotics
JPS5356661A (en) Novel amino glycoside antibiotics derivatives
MY103665A (en) Anthracycline glycosides
HK18683A (en) Antitumor anthracycline antibiotics
ES472284A1 (es) Procedimiento para la preparacion de 6-deoxineamina
IE45951L (en) Antitumour glycosides
ES8302733A1 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES472640A1 (es) Procedimiento para preparar seudotrisacaridos
AU512372B2 (en) Anthracycline glycoside antibiotics
AU506262B2 (en) Glycosyl derivatives of neamine
IE40946L (en) Aminoglycosides
MY102186A (en) Antitumor anthracycline glycosides, their preparation intermediate thereof, and compositions and use thereof
AU523746B2 (en) Anticancer composition
CA1016165A (en) 3'-deoxy derivatives of neamine and its related aminoglycosidic antibiotics, and the production thereof
CA1034524A (en) Antibiotic u-43,795 from streptomyces sviceus
AU463573B2 (en) Trialkylsilyl ethers of 11-alkyl-17-alkynylestra-1, 3, 5(10)-trien-3, 17-diols
JPS5227782A (en) Preparation of uridine derivatives
IE40748L (en) Antibiotic 20,798 r.p.
JPS5432493A (en) Preparation of macrolide antibiotics derivatives